The dexamethasone suppression test in the puerperium

Area of Science:

• Obstetrics and Gynecology
• Endocrinology
• Psychiatry

Background:

• The dexamethasone suppression test (DST) is used to assess hypothalamic-pituitary-adrenal (HPA) axis function.
• Postpartum hormonal changes can potentially influence HPA axis activity.

Purpose of the Study:

• To investigate the frequency of abnormal dexamethasone suppression test (DST) results in the early postpartum period.
• To determine if baseline cortisol levels correlate with postpartum mood and anxiety symptoms.

Main Methods:

• 45 women admitted to an obstetric unit were administered the DST on postpartum days 3-5.
• Participants completed the Beck Depression Inventory and the General Health Questionnaire at baseline and 6 weeks postpartum.
• Baseline cortisol levels were measured.

Main Results:

• 82% of women exhibited abnormal DST results within 3-5 days postpartum.
• The incidence of abnormal DSTs increased linearly with each testing day.
• Baseline cortisol levels did not correlate with baseline or 6-week postpartum mental health scores.

Conclusions:

• The early postpartum period is a significant factor contributing to false-positive DST results.
• The DST may not be a reliable indicator of HPA axis dysfunction in the immediate postpartum period.
• Further research is needed to understand HPA axis regulation postpartum.